April 24, 2023 – Medicinal Genomics Welcomes Cannabis Investors to CannMed 23 Innovation & Investment Summit, May 15-17, Marco Island, FL – “We’re very happy to be able to add the investment component to CannMed 23,” said Brendan McKernan, Medicinal Genomics CEO. “Every new market, especially those with as much potential as this one, attracts a great deal of interest. But it’s also uncharted territory. That’s why we’re thrilled to have a leader with David’s expertise and reputation, and why we’ve had such a great response.”
February 28, 2023 – Medicinal Genomics Unveils Its Compendium of State-by-State Cannabis Microbial Testing Regulations – We at Medicinal Genomics Corporation (MGC) have cataloged the cannabis microbial testing regulations by state as the first step in an effort to shed light on the disarray of the industry’s regulatory status.
February 27, 2023 – Medicinal Genomics Debuts Immersive Workshop Format at CannMed 23 – All the Workshops will be held on Monday, May 15th to allow attendees two full days at the conference proper. As always, CannMed gathers some of the foremost medicinal plant thought leaders, scientists, physicians, and advocates from around the world who will come together to present the latest advances in medicinal plant therapeutics on the conference’s final two days.
September 30, 2022 – New Research Shows that Cannabis Trichomes Trigger Positive Results on Rapid Yeast and Mold Plates – Kevin McKernan, Chief Scientific Officer and Founder of Medicinal Genomics, shares some insight behind his recently published paper related to cannabis trichomes and positive results on rapid yeast and mold plates. In a recent pre-print article by Kevin McKernan and Yvonne Helbert of Medicinal Genomics (1), they present latest findings from their laboratories demonstrating that certain trichome-rich strains can be mistaken for pathogen-rich samples.
July 5, 2023 – Scientists Identify Viroid-Resistant Purple Cannabis Strain – SFGate reports that scientists from Massachusetts-based Medicinal Genomics observed a cannabis variety, Jamaican Lion, that appears to be partially resistant to HLVd, and it turns purple as it fights the viroid.
April 24, 2023 – Medicinal Genomics Welcomes Cannabis Investors to CannMed 23 Innovation & Investment Summit, May 15-17, Marco Island, FL – “We’re very happy to be able to add the investment component to CannMed 23,” said Brendan McKernan, Medicinal Genomics CEO. “Every new market, especially those with as much potential as this one, attracts a great deal of interest. But it’s also uncharted territory. That’s why we’re thrilled to have a leader with David’s expertise and reputation, and why we’ve had such a great response.”
February 28, 2023 – Medicinal Genomics Unveils Its Compendium of State-by-State Cannabis Microbial Testing Regulations – We at Medicinal Genomics Corporation (MGC) have cataloged the cannabis microbial testing regulations by state as the first step in an effort to shed light on the disarray of the industry’s regulatory status.
February 27, 2023 – Medicinal Genomics Debuts Immersive Workshop Format at CannMed 23 – All the Workshops will be held on Monday, May 15th to allow attendees two full days at the conference proper. As always, CannMed gathers some of the foremost medicinal plant thought leaders, scientists, physicians, and advocates from around the world who will come together to present the latest advances in medicinal plant therapeutics on the conference’s final two days.
Media Contact: info@medicinalgenomics.com
©2024 MEDICINAL GENOMICS CORPS
Copyright all right reserved.
Signup to receive email updates on blog posts, podcasts, webinars, new products, and more!
Join us at the CannMed 24 Innovation and Investment Summit, an exclusive experience of discovery, development, and networking with innovators from around the world.
